About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Found 257 record(s)
Req # A-2021-001048
Adverse Drug Reaction (ADR) for TRIAMCINOLONE ACETONIDE. Report number: E2B_03676035.Organization: Health Canada
December 2021
Req # A-2021-001102
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-114800-669, Letter to the COVID-19 Exposure Notification App Advisory Council Members.Organization: Health Canada
December 2021
Req # A-2021-001104
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-115452-86, Deputy Ministers’ Cyber Security Committee.Organization: Health Canada
December 2021
Req # A-2021-001162
Adverse Drug Reaction (ADR) for FUROSEMIDE. Report number: E2B_03879484.Organization: Health Canada
December 2021
Req # A-2021-001227
Adverse Drug Reactions (ADRs) for LEFLUNOMIDE. Report numbers: E2B_04073816, E2B_02887421.Organization: Health Canada
December 2021
Req # A-2021-001262
Adverse Drug Reaction (ADR) for HYDROCORTISONE ACETATE. Report number: 000948912.Organization: Health Canada
December 2021
Req # A-2021-001433
Adverse Drug Reaction (ADR) for TRUVADA. Report number: E2B_04404472.Organization: Health Canada
December 2021
Req # A-2016-001559
Briefing materials provided by Health Canada to Brigadier-General H.C. MacKay (Surgeon General of the Canadian Armed Forces), and his office, regarding the drug Mefloquine also known under the brand name Lariam from July 1, 2016 to September 30, 2016.Organization: Health Canada
November 2021
Req # A-2017-000580
Documents submitted by sponsor in support of the safe use of Mannitol in this formulation indicated for the management of nausea and vomiting of pregnancy as well as all other documents, materials, regarding: PMS-DOXYLAMINE-PYRIDOXINE (Drug Identification Number (DIN 02406187)).Organization: Health Canada
November 2021
Req # A-2021-000242
The number of analysts/public servants processing access to information files, broken down by year and by category at Health Canada for the following years: 2015, 2016, 2017, 2018, 2019, 2020 and 2021 to date, May 14, 2021.Organization: Health Canada
November 2021